Regentis Biomaterials RGNT
NYSE RGNT
$2.06 -0.14 (-6.36%)
At close: Aug 20, 2026 · 4:00 PM EDT

Regentis Biomaterials (RGNT) Assets Average (2025)

Regentis Biomaterials (RGNT) posted quarterly Assets Average of $4.0 million for Q4 2025.

Regentis Biomaterials (RGNT) Assets Average (2025) Analysis & Trends

Regentis Biomaterials (RGNT) has reported Assets Average for 1 consecutive years, with $4.0 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Assets Average changed N/A year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (changed N/A YoY), while the FY2025 annual figure was $4.0 million, changed N/A from the prior year.
  • Assets Average was little changed at $4.0 million in Q4 2025 per RGNT's latest filing.
  • Across five years, Assets Average topped out at $4.0 million in Q4 2025 and bottomed at $4.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Intuitive Surgical 132.71 Bn 127.50 Bn 1.96 Bn 20.49 Bn
2 Becton Dickinson 51.57 Bn 50.71 Bn 2.32 Bn 50.78 Bn
3 Alcon 35.52 Bn 34.17 Bn 1.68 Bn 31.36 Bn
4 Resmed 33.28 Bn 31.81 Bn 861.22 Mn 8.88 Bn
5 Medline 27.86 Bn 25.18 Bn 2.22 Bn 39.18 Bn
6 West Pharmaceutical Services 25.15 Bn 24.71 Bn 329.20 Mn 4.09 Bn
7 Solventum 15.31 Bn 14.91 Bn 1.29 Bn 14.17 Bn
8 Cooper Companies 14.86 Bn 14.72 Bn 735.40 Mn 12.45 Bn
9 Baxter International 13.63 Bn 11.48 Bn 1.03 Bn 19.82 Bn
10 Regentis Biomaterials 1.20 Mn -6.18 Mn - 4.05 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.05 Mn